Luciano Adorini
Intercept Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
T-cell and B-cell Immunology, Immune Cell Function and Interaction, Immunotherapy and Immune Responses, Drug Transport and Resistance Mechanisms, Diabetes and associated disorders
Most-Cited Works
- → 1α,25-Dihydroxyvitamin D3 Inhibits Differentiation, Maturation, Activation, and Survival of Dendritic Cells Leading to Impaired Alloreactive T Cell Activation(2000)1,250 cited
- → THE INTERLEUKIN-12/INTERLEUKIN-12-RECEPTOR SYSTEM: Role in Normal and Pathologic Immune Responses(1998)1,245 cited
- → Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease(2013)906 cited
- → Maturation Stages of Mouse Dendritic Cells in Growth Factor–dependent Long-Term Cultures(1997)837 cited
- → Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease(2011)830 cited
- → Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development(2019)